Promising heart drug fails in trial — experts question inflammation theory of heart disease

A drug designed to target inflammation has failed its clinical trial, shocking experts and challenging the long-held theory that inflammation causes heart disease. The unexpected failure is prompting researchers to reassess the inflammation hypothesis. The results could reshape the direction of future cardiovascular drug development.